Rednix Pharma Private Limited

Rednix Pharma Private Limited - business services in Panchkula, Haryana, India. FY 2026 financials & compliance.
CIN U74999HR2019PTC078197 Incorporated 30 January 2019 ROC Delhi HQ Panchkula, Haryana, India
Active Private Limited Company business services
Data last updated
Revenue · FY 2024
₹29.4 Lakh
▲ 1% YoY
Net profit · FY 2024
₹89,371
Net margin 3%
EBITDA · FY 2024
₹1.57 Lakh
EBITDA margin 5.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Rednix Pharma Private Limited

Data last updated:

Rednix Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 30 January 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2019PTC078197. Its GSTIN is 06AAJCR3912J1ZA (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Kumar and Ashwani Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109.

As per the financials filed for FY 2024, the company reported a revenue of ₹29.4 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹89,371 (net margin 3%) and EBITDA of ₹1.57 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999HR2019PTC078197
Registration Number 078197
Incorporation Date 30 January 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Rednix Pharma Private Limited's registered office is in Panchkula, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Shop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services

To see the full contact details of Rednix Pharma Private Limited, buy the company report.

Comprehensive company report
Rednix Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rednix Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rednix Pharma Private Limited, buy the company report.

Financials of Rednix Pharma Private Limited

FY 2025 filings available

Rednix Pharma Private Limited reported revenue of ₹29.4 Lakh (up 1% YoY) for FY 2024.

Revenue · FY 2024
₹29.4 Lakh ▲ 1%
Net profit · FY 2024
₹89,371 margin 3%
EBITDA · FY 2024
₹1.57 Lakh margin 5.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 14%
5 years · compounded
▲ 64%

Revenue has grown at a compounded annual rate (CAGR) of 1% over three years, including 1% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.57 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹89,371
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.3%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rednix Pharma Private Limited, buy the company report.

Board of directors of Rednix Pharma Private Limited

Rednix Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sandeep KumarDirector30 Jan 20197 Years 9 MonthsCurrent
Ashwani SharmaDirector04 Mar 20197 Years 7 MonthsCurrent
Taranvir SinghDirector04 Jun 20197 Years 4 MonthsCurrent

Peer comparison

Rednix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Davideson Medipharma Private Limited₹29.41 Lakh (FY 2024)3.0%Deoria, Uttar Pradesh, India
Glorisa Technovation India Private Limited₹29.41 Lakh (FY 2025)-17.0%Ghaziabad, Uttar Pradesh, India
Octaglo Laboratories Private Limited₹29.41 Lakh (FY 2025)5.0%New Delhi, Delhi, India
Sar Multicomm Private Limited₹29.41 Lakh (FY 2024)9.0%New Delhi, Delhi, India
Vanam Imports and Exports Private Limited₹29.4 Lakh (FY 2025)-36.0%Madanapalle, Andhra Pradesh, India
Rednix Pharma Private Limitedthis company₹29.4 Lakh (FY 2024)₹89,3713%1.0%Panchkula, Haryana, India
Zanelini Apparel Private Limited₹29.4 Lakh (FY 2015)47.0%New Delhi, Delhi, India
Btree Industries Private Limited₹29.4 Lakh (FY 2022)314.0%Jaipur, Rajasthan, India
Shresha Museum Solutions Private Limited₹29.4 Lakh (FY 2025)-82.0%Thane, Maharashtra, India
CSD Sansar Infratec Cement Limited₹29.39 Lakh (FY 2016)-85.0%New Delhi, Delhi, India
Unicorn Beauty Private Limited₹29.39 Lakh (FY 2025)-69.0%Delhi, India

To see the full peer comparison of Rednix Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rednix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rednix Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAJCR3912J1ZAHaryanaActive27 Mar 2019

To see the full GST registrations and return filing status of Rednix Pharma Private Limited, buy the company report.

Recent activity

Rednix Pharma Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Ashwani Sharma ceased to be Additional Director on 30 Sep 2019.

AGM
Rednix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rednix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Ashwani Sharma ceased to be Additional Director.
Ceased
Taranvir Singh ceased to be Additional Director.
Appointed
Taranvir Singh was appointed as Director.
Appointed
Ashwani Sharma was appointed as Director.
Ceased
Bhushan Modgill ceased to be Director.
Appointed
Sandeep Kumar was appointed as Director.
Incorporation
30 Jan 2019
Rednix Pharma Private Limited was registered on 30 Jan 2019 with Roc Delhi & aged 7 years 9 months as per MCA records.

Frequently asked questions

Rednix Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 30 January 2019 (7+ years old) and is registered under CIN U74999HR2019PTC078197.

Rednix Pharma has 3 current directors:

The latest financial statements of Rednix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Rednix Pharma is 06AAJCR3912J1ZA, registered in Haryana.

The CIN (Corporate Identification Number) of Rednix Pharma is U74999HR2019PTC078197. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rednix Pharma was incorporated on 30 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Rednix Pharma by revenue are Davideson Medipharma Private Limited, Glorisa Technovation India Private Limited, Octaglo Laboratories Private Limited, Sar Multicomm Private Limited, Vanam Imports and Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Ashwani Sharma ceased to be Additional Director on 30 Sep 2019. Taranvir Singh ceased to be Additional Director on 30 Sep 2019. Taranvir Singh was appointed as Director on 04 Jun 2019. Rednix Pharma has 6 board changes on record in total.

The registered office of Rednix Pharma is at Shop No. 1 Chaudhary Complex Relly Sector 12A, Panchkula, Haryana, India – 134109.

Rednix Pharma operates in the business services industry, in the miscellaneous business activities segment.

The compliance status of Rednix Pharma is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.